![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/40 | |
A61K 39/00 | |||
A61K 39/395 |
(11) | Number of the document | 3169362 |
(13) | Kind of document | T |
(96) | European patent application number | 15760317.6 |
Date of filing the European patent application | 2015-07-16 | |
(97) | Date of publication of the European application | 2017-05-24 |
(45) | Date of publication and mention of the grant of the patent | 2020-06-10 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/040765 |
Date | 2015-07-16 |
(87) | Number | WO 2016/011260 |
Date | 2016-01-21 |
(30) | Number | Date | Country code |
201462025371 P | 2014-07-16 | US | |
201462043167 P | 2014-08-28 | US | |
201462080725 P | 2014-11-17 | US | |
201562132709 P | 2015-03-13 | US | |
15305830 | 2015-05-29 | EP |
(72) |
HANOTIN, Corinne, FR
BESSAC, Laurence, FR
CHAUDHARI, Umesh, US
PORDY, Robert, US
SCHWEMMER GIPE, Daniel A., US
|
(73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
Sanofi Biotechnology, 54 rue La Boétie, 75008 Paris, FR |
(54) | METHODS FOR TREATING HIGH CARDIOVASCULAR RISK PATIENTS WITH HYPERCHOLESTEROLEMIA |
METHODS FOR TREATING HIGH CARDIOVASCULAR RISK PATIENTS WITH HYPERCHOLESTEROLEMIA |